Pharmaceutical industry calling for more tax cuts on R&D spending

Published: 2008-12-22 06:59:00

Updated: 2008-12-22 06:59:00

The government’s long-term plans for the development of new drugs should focus on more tax cuts levied on research and development (R&D) reserves, facility investment for research and manpower development as well as technology transfer revenues, according to a university professor.

In a recent...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK